Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016

Watchlist Manager
Shanghai MicroPort Endovascular MedTech Group Co Ltd Logo
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Watchlist
Price: 102.44 CNY -5.91% Market Closed
Market Cap: 12.6B CNY
Have any thoughts about
Shanghai MicroPort Endovascular MedTech Group Co Ltd?
Write Note

Shanghai MicroPort Endovascular MedTech Group Co Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai MicroPort Endovascular MedTech Group Co Ltd
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Short-Term Investments
ÂĄ10.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Short-Term Investments
ÂĄ338.9m
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Short-Term Investments
ÂĄ3.3B
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Short-Term Investments
ÂĄ3.1B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Short-Term Investments
ÂĄ2.4B
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Intco Medical Technology Co Ltd
SZSE:300677
Short-Term Investments
ÂĄ5.3B
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai MicroPort Endovascular MedTech Group Co Ltd
Glance View

Market Cap
12.6B CNY
Industry
Health Care

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, production, and sale of aortic and peripheral vascular interventional medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 660 full-time employees. The company went IPO on 2019-07-22. The firm's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The firm mainly distributes its products to the domestic market.

Intrinsic Value
175.64 CNY
Undervaluation 42%
Intrinsic Value
Price

See Also

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Short-Term Investments?
Short-Term Investments
10.1m CNY

Based on the financial report for Dec 31, 2023, Shanghai MicroPort Endovascular MedTech Group Co Ltd's Short-Term Investments amounts to 10.1m CNY.

Back to Top